Indatuximab Biosimilar – Anti-SDC1, CD138 mAb – Research Grade

Reference:
Size

,

Isotype

IgG4, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameIndatuximab Biosimilar - Anti-SDC1, CD138 mAb - Research Grade
SourceCAS 1238517-16-2
SpeciesChimeric
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsIndatuximab,BT-062,nBT062-DM4,SDC1, CD138,anti-SDC1, CD138
ReferencePX-TA1277
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody

Description of Indatuximab Biosimilar - Anti-SDC1, CD138 mAb - Research Grade

General information on Anti-SDC1/CD138[Homo sapiens] (Indatuximab) Monoclonal Antibody

Indatuximab is investigated for the treatment of Relapsed or Refractory Multiple Myeloma.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Indatuximab Biosimilar – Anti-SDC1, CD138 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD138 Recombinant Protein
Antigen

CD138 Recombinant Protein

PX-P4106 500$
Human IgG4 Isotype Control antibody
Isotype Control

Human IgG4 Isotype Control antibody

PTX17887 214$
Indatuximab ELISA Kit
ELISA

Indatuximab ELISA Kit

KPTX205 1547$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products